In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

The Novo Nordisk Foundation started a dialog with Novo’s board “on the merits of an accelerated CEO succession,” Novo said, ...

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down after eight years at the helm, as the Danish pharmaceutical giant ...

The Citywest Hotel will be expanded following its purchase by the state to accommodate asylum seekers, the Irish Times ...

The papers are dominated by better deals expected with the EU and Sir Keir Starmer's pivot on winter fuel payments.

The credit rating agency Moody’s has stripped the United States of its triple-A credit rating, warning investors about rising levels of government debt and a widening budget deficit. The agency has ...

A 2023 test showing that Novo Nordisk (NYSE: NVO )’s Wegovy weight-loss medication not only helped people lose weight but ...

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a new study. For several years, researchers ...

Once the world’s most widely used dieting program, Weight Watchers’ parent company, WW International, recently entered ...

Novo Nordisk has filed another Citizen's Petition ... once-weekly drugs like semaglutide-based Ozempic and Wegovy – used for diabetes and obesity – the once-daily product still made more ...